Company News: Page (1) of 1 - 07/09/18 Email this story to a friend. email article Print this page (Article printing at page facebook

OBI Pharma Granted FDA Orphan Drug Designation for OBI-3424 for the Treatment of Hepatocellular Carcinoma (HCC)

First Orphan Drug Designation for OBI-3424, a novel first-in-class targeted therapy for solid tumors that express aldo-keto reductase 1c3 (AKR1C3) enzyme (July 09, 2018)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:Pro AV,Presentors,Business Issues,Presentation,People,USA,Taiwan, Inc.,Medicine,Disease,Cancer,Surgery,Science,Lifestyle,Medical,Biology,Genetics,Cancer,Other,


Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved